Home › Research › How common it is
Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study
Hung‐Wen Cheng, Shun‐Fa Yang, Pei‐Lun Liao, Chiu‐Hsian Lee, Gwo‐Ping Jong. Diabetes/Metabolism Research and Reviews, 2025-06-07
Topic: Risk, prevention and care in population studies
Plain-language summary
Among a cohort comprising 109,778 individuals, the use of GLP-1RA demonstrated a reduced risk of dementia compared with its non-use (aHR, 0.90; 95% CI, 0.83-0.97). Subgroup analyses stratified by different diabetic complications revealed significantly lower dementia incidence rates among GLP-1RAs users than among non-GLP-1RAs users. Individuals aged ≤ 75 years demonstrated a significant protective effect within GLP-1RAs users. The utilization of GLP-1 receptor agonists instead of non-GLP-1RAs medications demonstrated an association with a decreased incidence of dementia.
What this study adds
Evidence grade: Moderate
The record lists 109,778 participants. In this cohort of 109,778 people with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of dementia compared with non-use. The study reports an association and does not establish that these drugs prevent dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cheng, H., Yang, S., Liao, P., Lee, C., & Jong, G. (2025). Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70058
Vancouver
Cheng H, Yang S, Liao P, Lee C, Jong G. Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study. Diabetes/Metabolism Research and Reviews. 2025. doi:10.1002/dmrr.70058. PMID: 40481813.
BibTeX
@article{cheng2025-40481813,
author = {Cheng, Hung‐Wen and Yang, Shun‐Fa and Liao, Pei‐Lun and Lee, Chiu‐Hsian and Jong, Gwo‐Ping},
title = {{Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study}},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2025},
doi = {10.1002/dmrr.70058},
pmid = {40481813},
url = {https://doi.org/10.1002/dmrr.70058}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Among a cohort comprising 109,778 individuals, the use of GLP-1RA demonstrated a reduced risk of dementia compared with its non-use (aHR, 0.90; 95% CI, 0.83-0.97).
- Subgroup analyses stratified by different diabetic complications revealed significantly lower dementia incidence rates among GLP-1RAs users than among non-GLP-1RAs users.
- Individuals aged ≤ 75 years demonstrated a significant protective effect within GLP-1RAs users.
- The utilization of GLP-1 receptor agonists instead of non-GLP-1RAs medications demonstrated an association with a decreased incidence of dementia.
Why it matters
In this cohort of 109,778 people with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of dementia compared with non-use. The study reports an association and does not establish that these drugs prevent dementia.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Participants109,778
- Evidence strengthModerate
How this study scored 47/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Diabetes/Metabolism Research and Reviews) |
| Journal's citation record | 2 / 4 | Diabetes/Metabolism Research and Reviews: journal h-index 160 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 109,778 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 10 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 6.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Gwo‐Ping Jong: h-index 18 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Chung Shan Medical University: institution h-index 222 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40481813) |
| Free to read | 2 / 2 | Free to read |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/dmrr.70058
- PubMed: 40481813
- Original source →
- Free full text: Diabetes/Metabolism Research and Reviews →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.